文献速递妇产影像MR

多参数MRI有助于子宫内膜癌保留生育功能治疗前的患者筛选

Multiparametric magnetic resonance imaging facilitates the selection of patients prior to fertility-sparing management of endometrial cancer.
PubMed 文献 · Abdom Radiol (NY) · 2021-04-07

本多中心回顾性研究纳入48例年龄<46岁、1级子宫内膜样腺癌且不愿保留生育功能而接受确定性手术的潜在候选者,比较双参数MRI与多参数MRI对肌层浸润、宫颈间质受累、恶性附件病变及盆腔淋巴结转移的诊断效能,以手术病理为金标准。结果显示MRI整体诊断效能中等,多参数MRI在检测肿瘤超出子宫内膜方面优于双参数MRI。

要点

  • 多参数MRI在判断肿瘤超出子宫内膜方面优于双参数MRI,敏感度84%/90% vs 71%/77%。
  • 双参数与多参数MRI对肌层浸润、恶性附件病变及盆腔淋巴结转移的AUC相近。
  • T2WI上肿瘤最大径、肿瘤体积及肿瘤-子宫体积比诊断肌层浸润的AUC为0.61-0.77。

核心结论

  • MRI对保留生育功能治疗的子宫内膜癌潜在候选者诊断效能中等,多参数MRI在检测肿瘤超出子宫内膜方面优于双参数MRI。

研究设计与样本

  • 多中心回顾性研究,纳入48例年龄<46岁、1级子宫内膜样腺癌且不愿保留生育功能而接受确定性手术的潜在候选者。
  • 两名阅片者独立分析双参数MRI(T1、T2、DWI)和多参数MRI(双参数+DCE),间隔一个月,以手术病理为金标准。

关键影像表现/征象

  • 在T2WI上记录肿瘤最大径、肿瘤体积及肿瘤-子宫体积比。
  • 双参数与多参数MRI诊断肌层浸润的AUC分别为0.76/0.78和0.84/0.83(R1/R2)。
  • 双参数与多参数MRI诊断宫颈间质受累的AUC分别为0.79/0.76和0.99/0.80(R1/R2)。
  • 双参数与多参数MRI诊断恶性附件病变的AUC分别为0.84/0.84和0.84/0.80(R1/R2)。
  • 双参数MRI诊断盆腔淋巴结转移的AUC为0.82/0.82(R1/R2)。

诊断标准与关键数值

  • MRI检测肿瘤超出子宫内膜的敏感度/特异度:双参数MRI为71%/77%(R1)和71%/65%(R2);多参数MRI为84%/71%(R1)和90%/65%(R2)。
  • T2WI肿瘤最大径、肿瘤体积及肿瘤-子宫体积比诊断肌层浸润的AUC分别为0.71/0.61、0.73/0.75和0.75/0.77(R1/R2)。

临床应用与阅片要点

  • 对保留生育功能候选者,多参数MRI(含DCE)可能更利于排除肿瘤超出子宫内膜。
  • 双参数MRI对肌层浸润、附件病变及淋巴结转移的诊断效能与多参数MRI相近,可在无法使用对比剂时选用。

局限性

  • 回顾性研究,样本量较小(48例),仅纳入1级子宫内膜样腺癌且接受手术者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To compare the diagnostic performance of biparametric magnetic resonance imaging (bpMRI) versus multiparametric MRI (mpMRI) for the staging of well-differentiated endometrioid endometrial cancer (EC) in potential candidates for fertility-sparing management.

METHODS: This multi-center retrospective study included 48 potential candidates for fertility-sparing management (age <46 years, grade 1 endometroid EC) who did not wish to undergo fertility-sparing management and thus underwent definitive surgery. Two readers (R1, R2) independently reviewed bpMRI (T1, T2, and diffusion-weighted imaging) and mpMRI (bpMRI and dynamic contrast-enhanced imaging, DCE) during two separate sessions spaced one month apart for the presence of myometrial invasion (MI), cervical stromal involvement (CSI), malignant adnexal disease (mAD), and pelvic lymphadenopathy (pLNM). Each reader also recorded maximum tumor diameter, tumor volume, and tumor-to-uterine volume ratio (TVR) on T2-weighted imaging. The diagnostic performance of bpMRI and mpMRI was determined for each reader with surgical pathology serving as a gold standard.

RESULTS: The area under the receiver operating curve (AUC) for bpMRI versus mpMRI was 0.76/0.78 (R1/R2) versus 0.84/0.83 for MI, 0.79/0.76 versus 0.99/0.80 for CSI, 0.84/0.84 versus 0.84/0.80 for mAD, and 0.82/0.82 for pLMN. The sensitivity and specificity of MRI for detecting tumor spread beyond the endometrium were 71%/77% and 71%/65% for bpMRI (R1/R2) vs. 84%/90% and 71%/65% for mpMRI (R1/R2), respectively. The AUC of maximum tumor diameter, tumor volume, and TVR for MI was 0.71/0.61, 0.73/0.75, and 0.75/0.77 for R1/R2, respectively.

CONCLUSION: MRI had moderate diagnostic performance across potential candidates for fertility-sparing treatment of EC. mpMRI outperformed bpMRI for detecting EC spreading beyond the endometrium.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Himoto Y, Lakhman Y, Fujii S, et al. Multiparametric magnetic resonance imaging facilitates the selection of patients prior to fertility-sparing management of endometrial cancer. Abdom Radiol (NY). 2021. PMID: 33825929. doi:10.1007/s00261-021-03050-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。